-
51.发明公开
公开(公告)号：EP4119151A1
公开(公告)日：2023-01-18
申请号：EP21840771.6
申请日：2021-10-06
申请人： MD Healthcare Inc.
发明人： KIM, Yoon-Keun , LEE, Myoung-Jin
IPC分类号： A61K35/747 , A61K9/00 , A61P37/00 , A23L33/135 , A61K8/99 , A61P3/00 , A61Q19/00
摘要： The present invention relates to Lactobacillus paracasei-derived extracellular vesicles and a use thereof, and more particularly, to a composition for alleviating, preventing and treating an ocular disease, which comprises Lactobacillus paracasei-derived extracellular vesicles as an active ingredient, capable of effectively inhibiting the occurrence of an ocular disease caused by oxidative stress-mediated cell senescence.
-
公开(公告)号：EP4112064A1
公开(公告)日：2023-01-04
申请号：EP22181397.5
申请日：2022-06-27
申请人： ASC REGENITY Limited
发明人： GIRI, Shibashish
IPC分类号： A61K35/741 , A61K31/733 , A61K31/702 , A61K31/198 , A61K36/185 , A61K36/15 , A61K36/42 , A61K31/122 , A61K31/593 , A61K35/747 , A61K35/744 , A61K31/7048 , A61K31/366 , A61K31/202 , A61K38/40 , A61K31/455 , A61K31/197 , A61K31/4415 , A61K36/81 , A61K31/375
摘要： A probiotic based skin care nutraceutical composition comprising human friendly intestinal microbes and a grow medium having pomegranate extract comprising Punicalagins, Ellagitannin, Punicic acid, Ellagitannis, wherein the microbes reaching inside human body to create an ambient environment for these friendly microbes to live and multiply in human body to kick start and activate cellular and molecular regenerative factors that activates producing Urolithin A in good quantity and in natural way, create the telomerase enzyme in optimal, create optimal level of nitric oxide inside human body, secrete collagen 17, stimulate glutathione enzyme level naturally and erase of free radicals of contaminated facial skin cell, activates facial endogenous stem cells ER internally efficiently in natural way to act as a skin progenitor for new facial skin regeneration.
-
53.发明公开
公开(公告)号：EP4101315A1
公开(公告)日：2022-12-14
申请号：EP21750538.7
申请日：2021-01-26
发明人： MURAKAMI, Hiroki , KO, Taro , ISHIMOTO, Hiroshi , KAMIKOUCHI, Azusa , MORI, Ikue
IPC分类号： A23L33/135 , A23K10/16 , A61K35/745 , A61K35/747 , A61P25/20 , A23C9/123 , A23L2/00 , A23L2/38
摘要： An object of the present invention is to provide a composition for promoting sleep, that enables an increase of the sleep amounts in the overall night and in the initial stage of the night, a decrease of the sleep onset latent time, and an increase of the length of a sleep episode, and that is excellent in the stability and the safety. Another object of the present invention is to provide a food, a drug, and a feed that each include the composition for promoting sleep. The composition for promoting sleep is characterized in that the composition for promoting sleep includes a microorganism belonging to either Bifidobacterium adolescentis or Lactobacillus plantarum , or a culture thereof as an active ingredient.
-
公开(公告)号：EP4095231A1
公开(公告)日：2022-11-30
申请号：EP20917302.0
申请日：2020-12-30
申请人： Hem Pharma Inc.
发明人： JI, Yo Sep , PARK, So Young
IPC分类号： C12N1/20 , A61K35/747 , A61P29/00 , A61P11/06 , A23L33/135 , C12R1/225
摘要： The present disclosure relates to a strain of Lactobacillus sakei HEM224 (KCTC14065BP) and a composition for treating, preventing or alleviating inflammation or asthma, comprising the strain.
A strain of Lactobacillus sakei HEM224 (KCTC14065BP) according to an embodiment of the present disclosure inhibits the production of pro-inflammatory factors or inflammatory factors, and exhibits an effect of treating asthma in an asthma animal model. Therefore, the strain can be applied to pharmaceutical compositions, food compositions, health functional food compositions and feed compositions for treating, preventing or alleviating inflammation or asthma.-
55.发明公开
公开(公告)号：EP4094590A1
公开(公告)日：2022-11-30
申请号：EP21176330.5
申请日：2021-05-27
申请人： Tate & Lyle Solutions USA LLC , Teagasc - The Agriculture and Food Development Authority , University College Cork - National University of Ireland, Cork
发明人： Caplice, Noel , Stanton, Catherine , Ross, Paul , Herisson, Florence , Karnik, Kavita , De Souza, Mervyn , Laurie, Leva , Canene-Adams, Kirstie
IPC分类号： A23L29/269 , A23L33/135 , A23L33/21 , A61K35/747
摘要： The present disclosure provides compositions comprising Lactobacillus mucosae and soluble dietary fiber, and methods treatment related thereto, useful against metabolic syndrome and related diseases, disorders and morbidities.
-
公开(公告)号：EP4070670A1
公开(公告)日：2022-10-12
申请号：EP21167470.0
申请日：2021-04-08
申请人： University College Cork-National University of Ireland Cork , Agriculture and Food Development Authority (TEAGASC)
发明人： O'Toole, Paul , van Sinderen, Douwe , Ross, Paul , Melgar, Silvia
IPC分类号： A23L33/135 , A23L33/00 , A61K35/747 , A61P1/00 , A61P3/10 , A61P37/08 , C12N1/20 , C12R1/225 , A61P37/02
摘要： A strain of Lacticaseibacillus paracasei EM205-11 is described. The strain has an unusually broad catabolic activity including for prebiotics not normally utilized by commensal lactobacilli (Fig. 13) and is therefore suitable for inclusion in a synbiotic combination. The strain has also been found to adhere to but did not invade intestinal epithelial cells (IECs), which is an important probiotic trait (Fig. 1), and also demonstrates anti-inflammatory activity.
-
57.发明公开
公开(公告)号：EP4051780A1
公开(公告)日：2022-09-07
申请号：EP20807477.3
申请日：2020-10-23
申请人： VF Bioscience
发明人： CUDENNEC, Benoit , COUTTE, François , DHULSTER, Pascal , DRIDER, Djamel , FLAHAUT, Christophe , FREMONT, Marc , RAVESCHOT, Cyril , VAEREMANS, Maxime , DEMBEREL, Shirchin , DUGERSUREN, Jamyan
IPC分类号： C12N1/20 , A61K35/747 , A23L33/135 , A23C9/123 , C12R1/25 , C12R1/225
-
58.发明授权
公开(公告)号：EP3033091B1
公开(公告)日：2022-09-07
申请号：EP14836942.4
申请日：2014-08-14
发明人： EI-NEZAMY, Hani , LEE, Pui Yue , HUANG, Jiandong , SUNG, Ying Ju
IPC分类号： A61K35/744 , A61K35/745 , A61K35/747 , A61P35/00
-
59.发明公开
公开(公告)号：EP3895719A9
公开(公告)日：2022-08-17
申请号：EP19896691.3
申请日：2019-11-28
发明人： CHOI, Hak Jong , YUN, Mi Sun
IPC分类号： A61K35/747 , A61P35/00 , A23L33/135 , A23K10/18
摘要： The present invention relates to a novel Lactobacillus sakei WIKIM30 (Accession No. KCCM11878P) isolated from kimchi and a composition comprising the same as an active ingredient. Lactobacillus sakei WIKIM30 according to the present invention shows excellent anti-cancer activity in animal models in which a cancer cell is transplanted and cancer cell lines, and therefore it can be usefully used as a composition in use of treatment, prevention or improvement of cancer of humans or animals.
-
-
-
-
-
-
-
-
-
搜索结果
864 条记录 (耗时 0.022 秒)
